The number of COVID-19 cases in the U.S. continues to rise as we enter the end of 2021, largely thanks to the Delta variant of the virus. Delta cases account for the vast majority of cases in hospitals – including Rochester Regional Health.
With this variant dominating the healthcare industry and public conversation about COVID-19, it begs the question: what about other variants?
We took that question and several others to Emil Lesho, DO, an infectious disease specialist with Rochester Regional Health who has been deeply involved in studying the virus and its effects over the last two years.
Variants are mutations of a virus. Virus particles spread by getting inside of your body, latching onto your cells, and copying themselves. Sometimes when they are copying themselves, there is a mistake and a slight change is made – creating a new variant. The more a virus spreads, the more opportunities there are for new variants to emerge.
With all viruses, some variants simply die off for various reasons, while others stay around for longer periods. With COVID-19, the SARS-CoV-2 Interagency Group (SIG) has created four classes of variants to track which ones could potentially have an impact on therapeutics, vaccines, and other viral treatments:
Currently, all PCR and antigen tests work for all variants of COVID-19. However, the results of these specific tests will not display which variant a person may have.
“A PCR test, which is the most commonly used COVID test, will run a sample to find viral genetic material,” Dr. Lesho said. “Those typically show results in 24-48 hours. Genome sequencing is used to see which of the variants are in the virus. This is a more detailed type of test, so it takes longer to complete and is usually done in larger laboratories.”
By using a nationwide system of larger laboratories to track cases involving variants, the CDC and other public health agencies can figure out how widespread any given variant is and how it might be changing as it spreads.
People who receive the COVID-19 vaccine are better protected against severe symptoms, hospitalization, and death as compared to people who do not get the vaccine.
“While the effect of future variants on the efficacy of the vaccines is unknown, the current data shows those who are vaccinated are protected from COVID infections in the vast majority of cases,” Dr. Lesho said.
As with all viruses, variants continue to change as they replicate. There will be more variants, but there is not enough current data to determine how contagious they might be.
No single method of treatment or therapeutics can prevent 100 percent of COVID-19 cases. But all our current research shows the best way to prevent the spread of COVID-19 and any current or future variants is to get vaccinated.
Scientists and researchers have determined the COVID-19 vaccines currently offered by Pfizer-BioNTech, Moderna, and Johnson & Johnson provide better protection against the virus and any variants when compared to other treatments or preventative therapies.
Other important ways you can protect yourself and your loved ones include:
Some of the region's top epidemiologists and infection specialists at Rochester Regional Health provide the most up-to-date information for questions about the vaccine and the virus.Learn More
Taking care of our bodies and minds is important at every age. During Men’s Health Month, we break down the recommended health screenings for men across all age groups.
Over the course of a few months, Rob Pinson went from relatively healthy to undergoing cancer treatment. The staff at the Lipson Cancer Institute were there for him every step of the way.
Strokes are among the top 3 causes of death for women in the United States. If you know the risks, you have a better chance at reducing or preventing your risk of stroke.